Next47 has participated in a $205m series D round for Verkada while UPMC Enterprises has co-led SparingVision’s $75m series B.

Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.

Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.

Alphabet led a $1bn round for its Verily subsidiary while Kimco Realty and The Silverman Group were part of Gotham Greens’ $310m series E.

Hitachi grows its cell therapy portfolio, SoftBank slims down in India and Foresight Williams backs ID tags for diamonds.

Hanwha Group took part in a $250m round for Carrot General Insurance while JP Morgan Chase helped lift LetsGetChecked’s series D to $170m.

SoftBank, Bristol Myers Squibb and Hitachi were among Arsenal Biosciences’ $220m round while MegaChips led a $140m round for Morse Micro.

SHV and DELA took part in an $80m round for Lightyear while Tata Sons provided $40m in funding for Tata 1mg.

The move comes as Schenker Ventures seeks to further expand its investment team

After two years at venture firm Verve Ventures, João Duarte has taken up a Switzerland-based senior manager role at eBay Ventures.